CEACAM5 and neoplasm: In our study, a new serum inflammatory-tumor biomarker system, the NLCECA score based on NLR, CEA, and CA19-9, was established, and it accurately reflected the tumor growth and proliferation level, as well as the body and tumor inflammatory immune status.